Compile Data Set for Download or QSAR
Report error Found 223 Enz. Inhib. hit(s) with all data for entry = 10923
Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 50502733BDBM50502733(CHEMBL4446699 | US11479539, Compound 80)
Affinity DataEC50:  2nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578561BDBM578561(US11479539, Compound 81 | US11479539, Compound 179...)
Affinity DataEC50:  2nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578558BDBM578558(US11479539, Compound 78 | 3-[3-(1,3- dimethylpyraz...)
Affinity DataEC50:  2nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 50502732BDBM50502732(CHEMBL4557371 | US11479539, Compound 69)
Affinity DataEC50:  2nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578556BDBM578556(US11479539, Compound 76 | 3-[5-fluoro-3-(2- methyl...)
Affinity DataEC50:  3nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578557BDBM578557(US11479539, Compound 77 | 3-[3-(2,6- dimethyl-4- p...)
Affinity DataEC50:  4nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578676BDBM578676(US11479539, Compound 211 | 3-methoxy-5,5- dimethyl...)
Affinity DataEC50:  4nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578572BDBM578572(US11479539, Compound 93 | 3-[3-(2,4- dimethylthiaz...)
Affinity DataEC50:  5nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578683BDBM578683(US11479539, Compound 219 | 3-[5-fluoro-3- (pyrazol...)
Affinity DataEC50:  5nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578552BDBM578552(US11479539, Compound 72 | US11479539, Compound 166...)
Affinity DataEC50:  6nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578697BDBM578697(US11479539, Compound 233 | 3-(5'-ethyl-5-fluoro[3,...)
Affinity DataEC50:  6nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578668BDBM578668(US11479539, Compound 203 | 3-[5-fluoro-3- (pyrazol...)
Affinity DataEC50:  6nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 50502727BDBM50502727(CHEMBL4584154 | US11479539, Compound 48)
Affinity DataEC50:  6nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578686BDBM578686(US11479539, Compound 222 | 3-[5'-(2-cyanopropan-2-...)
Affinity DataEC50:  6nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578564BDBM578564(US11479539, Compound 84 | 3-[5-fluoro-3-(5- fluoro...)
Affinity DataEC50:  6nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578565BDBM578565(US11479539, Compound 85 | 2'-(3-cyano-1- methoxy-5...)
Affinity DataEC50:  6nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 50502725BDBM50502725(CHEMBL4565642 | US11479539, Compound 168)
Affinity DataEC50:  7nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578561BDBM578561(US11479539, Compound 81 | US11479539, Compound 179...)
Affinity DataEC50:  7nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578574BDBM578574(US11479539, Compound 96 | 3-(5-fluoro-5'- (methyls...)
Affinity DataEC50:  7nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578677BDBM578677(US11479539, Compound 212 | 3-[5-fluoro-3- ([1,2,4]...)
Affinity DataEC50:  7nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578685BDBM578685(US11479539, Compound 221 | 3-{5-fluoro-5'-[(propan...)
Affinity DataEC50:  8nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 50502728BDBM50502728(CHEMBL4542755 | US11479539, Compound 174)
Affinity DataEC50:  8nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578568BDBM578568(US11479539, Compound 88 | US11479539, Compound 185...)
Affinity DataEC50:  8nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578558BDBM578558(US11479539, Compound 78 | 3-[3-(1,3- dimethylpyraz...)
Affinity DataEC50:  8nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578568BDBM578568(US11479539, Compound 88 | US11479539, Compound 185...)
Affinity DataEC50:  9nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578566BDBM578566(US11479539, Compound 86 | 3-[3-(1- ethylpyrazol-4-...)
Affinity DataEC50:  9nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578551BDBM578551(US11479539, Compound 71 | US11479539, Compound 164...)
Affinity DataEC50:  9nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578669BDBM578669(US11479539, Compound 204 | 3-methoxy-5,5- dimethyl...)
Affinity DataEC50:  9nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578698BDBM578698(US11479539, Compound 234 | 3-(5-fluoro-2'-methoxy-...)
Affinity DataEC50:  9nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578486BDBM578486(US11479539, Compound 5 | US11479539, Compound 124)
Affinity DataEC50:  10nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578684BDBM578684(US11479539, Compound 220 | 3-[5-fluoro-3- (pyridaz...)
Affinity DataEC50:  10nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578693BDBM578693(US11479539, Compound 229 | 3-[5-fluoro-3-(2- methy...)
Affinity DataEC50:  10nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578569BDBM578569(US11479539, Compound 89 | 3-[5-fluoro-3-(2- methyl...)
Affinity DataEC50:  11nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578522BDBM578522(US11479539, Compound 41 | US11479539, Compound 147...)
Affinity DataEC50:  11nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578570BDBM578570(US11479539, Compound 90 | 3-[5-fluoro-3-[6- (trifl...)
Affinity DataEC50:  11nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578681BDBM578681(US11479539, Compound 217 | 2'-[3-cyano-1-methoxy- ...)
Affinity DataEC50:  12nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578556BDBM578556(US11479539, Compound 76 | 3-[5-fluoro-3-(2- methyl...)
Affinity DataEC50:  12nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578689BDBM578689(US11479539, Compound 225 | 3-(3,5-dichloropyridin-...)
Affinity DataEC50:  12nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 50502725BDBM50502725(CHEMBL4565642 | US11479539, Compound 168)
Affinity DataEC50:  12nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578495BDBM578495(US11479539, Compound 14 | US11479539, Compound 111...)
Affinity DataEC50:  12nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578572BDBM578572(US11479539, Compound 93 | 3-[3-(2,4- dimethylthiaz...)
Affinity DataEC50:  12nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578515BDBM578515(US11479539, Compound 34 | US11479539, Compound 139...)
Affinity DataEC50:  12nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578690BDBM578690(US11479539, Compound 226 | 3-[5-fluoro-3- (imidazo...)
Affinity DataEC50:  13nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 50502726BDBM50502726(CHEMBL4583328 | US11479539, Compound 55)
Affinity DataEC50:  14nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 50502732BDBM50502732(CHEMBL4557371 | US11479539, Compound 69)
Affinity DataEC50:  14nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578552BDBM578552(US11479539, Compound 72 | US11479539, Compound 166...)
Affinity DataEC50:  14nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578688BDBM578688(US11479539, Compound 224 | 3-(3-chloro-5- fluoropy...)
Affinity DataEC50:  14nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578687BDBM578687(US11479539, Compound 223 | 3-[5'-(difluoromethoxy)...)
Affinity DataEC50:  14nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578550BDBM578550(US11479539, Compound 70 | US11479539, Compound 163...)
Affinity DataEC50:  15nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Targethek293 luciferase(HIV-1)
Medimmune

US Patent
LigandChemical structure of BindingDB Monomer ID 578567BDBM578567(US11479539, Compound 87 | US11479539, Compound 186...)
Affinity DataEC50:  15nMAssay Description:Purpose of the AssayThe purpose of this assay is to identify small molecule inhibitors of Keap1, preventing Keap1 binding to Nrf2, and thus activatin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Displayed 1 to 50 (of 223 total ) | Next | Last >>
Jump to: